Cargando…

Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease

Detalles Bibliográficos
Autores principales: Al Tabaa, Omar, Ghossan, Roba, Combier, Alice, Steelandt, Alexia, Thomas, Marion, Avouac, Jerome, Allanore, Yannick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923347/
https://www.ncbi.nlm.nih.gov/pubmed/36754549
http://dx.doi.org/10.1136/rmdopen-2022-002832
_version_ 1784887718565642240
author Al Tabaa, Omar
Ghossan, Roba
Combier, Alice
Steelandt, Alexia
Thomas, Marion
Avouac, Jerome
Allanore, Yannick
author_facet Al Tabaa, Omar
Ghossan, Roba
Combier, Alice
Steelandt, Alexia
Thomas, Marion
Avouac, Jerome
Allanore, Yannick
author_sort Al Tabaa, Omar
collection PubMed
description
format Online
Article
Text
id pubmed-9923347
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-99233472023-02-14 Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease Al Tabaa, Omar Ghossan, Roba Combier, Alice Steelandt, Alexia Thomas, Marion Avouac, Jerome Allanore, Yannick RMD Open Systemic Sclerosis BMJ Publishing Group 2023-02-08 /pmc/articles/PMC9923347/ /pubmed/36754549 http://dx.doi.org/10.1136/rmdopen-2022-002832 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Systemic Sclerosis
Al Tabaa, Omar
Ghossan, Roba
Combier, Alice
Steelandt, Alexia
Thomas, Marion
Avouac, Jerome
Allanore, Yannick
Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease
title Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease
title_full Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease
title_fullStr Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease
title_full_unstemmed Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease
title_short Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease
title_sort sustained complete b cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease
topic Systemic Sclerosis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923347/
https://www.ncbi.nlm.nih.gov/pubmed/36754549
http://dx.doi.org/10.1136/rmdopen-2022-002832
work_keys_str_mv AT altabaaomar sustainedcompletebcelldepletionisassociatedwithrituximabefficacyinconnectivetissuedisordersassociatedinterstitiallungdisease
AT ghossanroba sustainedcompletebcelldepletionisassociatedwithrituximabefficacyinconnectivetissuedisordersassociatedinterstitiallungdisease
AT combieralice sustainedcompletebcelldepletionisassociatedwithrituximabefficacyinconnectivetissuedisordersassociatedinterstitiallungdisease
AT steelandtalexia sustainedcompletebcelldepletionisassociatedwithrituximabefficacyinconnectivetissuedisordersassociatedinterstitiallungdisease
AT thomasmarion sustainedcompletebcelldepletionisassociatedwithrituximabefficacyinconnectivetissuedisordersassociatedinterstitiallungdisease
AT avouacjerome sustainedcompletebcelldepletionisassociatedwithrituximabefficacyinconnectivetissuedisordersassociatedinterstitiallungdisease
AT allanoreyannick sustainedcompletebcelldepletionisassociatedwithrituximabefficacyinconnectivetissuedisordersassociatedinterstitiallungdisease